Parvin Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Parvin Asset Management's AMGN Position: Q2 2026 in Review
Parvin Asset Management reduced its Amgen (AMGN) stake by 2.1% in Q2 2026, selling an estimated $41.1K and leaving 5,619 shares worth $2.03M. The position accounts for 1.6% of the portfolio, ranked #10.
Parvin Asset Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Parvin Asset Management held 5,619 shares of Amgen worth $2.03M as of Q2 2026.
- Parvin Asset Management sold 120 Amgen shares in Q2 2026, an estimated $41.1K.
- Amgen made up 1.6% of Parvin Asset Management's portfolio in Q2 2026, its #10 holding.
- Parvin Asset Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Parvin Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.